2021 ARTICLE – REPRODUCING SCALP MICROBIOTA ON RHE_IJCS
FOCUS 02.21 – Food Supplements Pre-clinical Testing Platform
VitroScreen has developed a precise, sensitive and quantitative […]
FOCUS 01.21 – Welcome ISO 10993-23!
VitroScreen supports the Medical Devices (MD) industry providing […]
FOCUS 08.20 – VitroScreen Season’s Greetings
Approaching the end of 2020, in the midst […]
2020 ARTICLE – DRY EYE DISEASE TREATMENT _ EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
2020 ARTICLE – IN VITRO EVALUATION OF SEAWATER-BASED SOLUTIONS _ MD: EVIDENCE AND RESEARCH
-
FOCUS 07.20 – VitroScreen has signed an Agency Agreement with Takis Foustanos & CO with the aim of expanding its presence in Greece, Turkey, Cyprus and BulgariaFOCUS 07.20 – VitroScreen has signed an Agency Agreement with Takis Foustanos & CO with the aim of expanding its presence in Greece, Turkey, Cyprus and Bulgaria
FOCUS 07.20 – VitroScreen has signed an Agency Agreement with Takis Foustanos & CO with the aim of expanding its presence in Greece, Turkey, Cyprus and Bulgaria
Marisa Meloni, VitroScreen’s CEO commenting the agreement said: “We are particularly […]
JANUARY 2019, XXIXÈMES JOURNÉES EUROPÉENNES DE DERMOCOSMÉTOLOGIE
“Intercellular exchanges in cutaneous tissues: which prospects […]
